Медицинская литература. Новинки

 

 

 

 

 

 

Ультразвуковое исследование с контрастным усилением в дифференциальной диагностике образований поджелудочной железы. Обзор литературы

Вы можете загрузить полный текст статьи в формате pdf

Роль УЗИ как неивазивного метода первичной оценки состояния поджелудочной железы уже хорошо известна. Появление ультразвуковых контрастных средств позволило значительно повысить возможности методики в выявлении и дифференциальной диагностике заболеваний поджелудочной железы. Анализ литературы за последние 20 лет показал преимущества и недостатки различных ультразвуковых методик в оценке очаговых изменений поджелудочной железы.

Ключевые слова:
ультразвуковая диагностика, контраст, поджелудочная железа, ultrasound, contrast, pancreas

Литература:
1.D’Onofrio M., Biagioli E., Gerardi C. et al. Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) and Contrast-Enhanced Endoscopic Ultrasound (ECEUS) for the Differentiation of Pancreatic Lesions: A Systematic Review and Meta-Analysis. Ultraschall Med. 2014; 35: 515-521.
2.Kitano M., Sakamoto H., Kudo M. Contrast-enhanced endoscopic ultrasound. Dig. Endosc. 2014; 26, Suppl. 1. 79-85.
3.Bang J.Y., Varadarajulu Sh. Neoplasia in Chronic Pancreatitis: How to Maximize the Yield of Endoscopic Ultrasound-Guided Fine Needle Aspiration. Clin. Endosc. 2014; 47: 420-424.
4.Tomiyama T., Tano S., Ueno N. et al. Contrast enhancend color Doppler ultrasonography in diagnosis of pancreatic tumor, two case reports. J. Ultrasound Med. 1996; 15 (7): 1024-1029.
5.Черешнева Ю.Н., Митьков В.В. Контрастные вещества в ультразвуковой диагностике (обзор литературы). Ультразвуковая диагностика. 1999; 2: 88-96.
6.Schwarz K.Q., Chen X., Steinmetz S. et al. Harmonic Imaging with Levovist. J. Am. Soc. Echocardiogr. 1997; 10 (1): 1-10.
7.Зубарев А.В. Трехмерная и эхоконтрастная ангиография. Медицинская визуализация. 1997; 4: 3-8.
8.Hosten N., Steger W., Bechstein W.O. et al. Vascularization patterns in focal liver lesion comparison of plain and signal-enhancement after intravenous injection of the ultrasound contrast agent Levovist. J. Clin. Ultrasound. 1996; 1 (24) : 31-35.
9.Камалов Ю.Р., Сандриков В.А., Гаврилов А.В. Использование ультразвукового контраста Levovist при обследовании больных c опухолями печени, портальной гипертензией и при ортотопической трансплантации печени. Клиническая физиология. Диагностика - новые методы; Под. ред. Сандрикова В.А. М.: Аир-Арт, 1998. 144-149.
10.Щербакова С.В., Кунцевич Г.И., Чебышева Э.Н. и др. Оценка результатов исследования кровотока у больных хронических панкреатитом и раком поджелудочной железы с помощью Левовиста. Клиническая физиология. Диагностика - новые методы; Под. ред. Сандрикова В.А. М.: Аир-Арт, 1998. 149-150.
11.Ishii M., Kawauchi A., Sakamoto M. et al. Evaluation of blood inside hepatic tumors using color Doppler echography with galactose-based intravenous contrast medium SH U 508 A administration. Nippon Rinsho. 1998; 4 (56) : 975-979.
12.Greis C. Contrast-Enhanced Ultrasound in General Imaging. Springer-Verlag, 2005. 43 p.
13.Piscaglia F. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med. Biol. 2006; 32: 1369-1375.
14.Фомина С.В., Завадовская В.Д., Юсубов М.С. и др. Контрастные препараты для ультразвукового исследования. Бюллетень сибирской медицины. 2011; 6: 137-142.
15.Seidel G., Meyer K. Impact of ultrasound contrast agents in cerebrovascular diagnostics. Eur. J. Ultrasound. 2002; 16 (1-2): 81-90.
16.Новиков Н.Е. Контрастно-усиленные ультразвуковые исследования. История развития и современные возможности. REJR. 2012; 2 (1): 20-28.
17.Cosgrove D.O. Ultrasound contrast agent. In: Meire H., Cosgrove D.O., Dewbury K., Farrant P. (Eds.) Clinikal ultrasound - a comprehensive text. Abdominal and general ultrasound. Churchill Livingstone. 2001. 67-79.
18.Lampaskis M., Averkiou M. Investigation of the relationship of nonlinear backscattered ultrasound intensity with microbubble concentration at low MI. Ultrasound Med. Biol. 2012; 36 (2): 306-312.
19.Gheonea D., Streba C., Ciurea T., Saftoiu A. Quantitative low mechanical index contrastenhanced endoscopic ultrasound for the differential diagnosis of chronic pseudotumoral pancreatitis and pancreatic cancer. BMC Gastroenterology. 2013; 13: 2.
20.Dietrich C.F., Braden B., Hocke M. et al. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J. Cancer. Res. Clin. Oncol. 2008; 134: 635-643.
21.Averkiou M., Powers J., Skyba D. et al. Ultrasound contrast imaging research. Ultrasound Q. 2003; 19: 27-37.
22.Claudon M., Cosgrove D., Albrecht T. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008. Ultraschall Med. 2008; 29: 28-44.
23.Piscaglia F., Nolsoe C., Dietrich C.F. et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012; 33: 33-59.
24.D’Onofrio M., Zamboni G., Tognolini A. et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. Wld J. Gastroenterol. 2006; 12: 41814184.
25.Kersting S., Konopke R., Kersting F. et al. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology. 2009; 137: 1903-1911.
26.D’Onofrio M., Mansueto G., Falconi M. et al. Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom. Imaging. 2004; 29: 246-258.
27.Malago R., D’Onofrio M., Zamboni G.A. et al. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. Am. J. Roentgenol. 2009; 192: 424-430.
28.D’Onofrio M., Barbi E., Dietrich C.F. Pancreatic multicenter ultrasound study (PAMUS). Eur. J. Radiol. 2012; 81(4): 630-638.
29.Itoh T., Hirooka Y., Itoh A. et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am. J. Gastroenterol. 2005; 100: 144-152.
30.D’Onofrio M., Megibow A.J., Faccioli N. et al. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. Am. J. Roentgenol. 2007; 189: 1435-1442.
31.Rickes S., Wermke W. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound. J. Gastroenterol. Hepatol. 2004; 19: 761-766.
32.Borbath I. Endoscopic ultrasound''s best-of in 2009: TOP 5 of the scientific literature. Acta Endoscopica. 2010; 40: 132-137.
33.Fusaroli P., Kypraios D., Caletti G. et al. Pancreatico-biliary endoscopic ultrasound: a systematic review of the levels of evidence, performance and outcomes. Wld J. Gastroenterol. 2012; 18: 4243-4256.
34.D''Onofrio M., Malago R., Zamboni G. et al. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology. 2005; 5: 398-402.
35.Dietrich C.F., Ignee A., Braden B. et al. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin. Gastroenterol. Hepatol. 2008; 6: 590-597.
36.D’Onofrio M., Gallotti A., Pozzi Mucelli R. Imaging techniques in pancreatic tumors. Expert Rev. Med. Devices. 2010; 7: 257-273.
37.Ripolles T., Martinez M.J., Lopez E. et al. Contrast-enhanced ultrasound in the staging of acute pancreatitis. Eur. Radiol. 2010; 20: 2518-2523.
38.Kobayashi A., Yamaguchi T., Ishihara T. et al. Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut. 2005; 54: 1047.
39.Tawada K., Yamaguchi T., Kobayashi A. et al. Changes in tumor vascularity depicted by contrast-enhanced ultrasonography as a predictor of chemotherapeutic effect in patients with unresectable pancreatic cancer. Pancreas. 2009; 38: 30-35.
40.Vicente E., Quijano Y., Ielpo B. et al. Is arterial infiltration still a criterion for unresectability in pancreatic adenocarcinoma? Cir. Esp. 2014; 92 (5): 305-315.
41.Beyer-Enke St., Hocke M., Ignee A. et al. Contrast Enhanced Transabdominal Ultrasound in the Characterisation of Pancreatic Lesions with Cystic Appearance. J. Pancreas. 2010; 11 (5): 427-433.
42.Grossjohann H.S. сontrast-enhancend ultrasound for diagnosing, standing and assessment of operability of pancreatic cancer. Dan. Med. J. 2012; 59 (12): B4536.
43.Faccioli N., D’Onofrio M., Malago R. et al. Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas. 2008; 37: 265-268.
44.Ang T.L., Teo E.K., Ang D. et al. A pilot study of contrast harmonic endosonography using DEFINITYtm in the evaluation of suspected pancreatic and peri-ampullary malignancies. J. Interv. Gastroenterol. 2011; 1 (4): 160-165.
45.Kersting St., Roth J., Bunk A. Transabdominal Contrast-Enhanced Ultrasonography of Pancreatic Cancer Pancreatology. 2011; 11 (Suppl. 2): 20-27.
46.Кармазановский Г.Г., Кригер А.Г., Ветшева Н.Н. и др. Метастазы почечно-клеточного рака в поджелудочную железу (обзор литературы и клинический пример). Медицинская визуализация. 2012;4: 49-54.
47.Saftoiu A., Iordache S.A., Gheonea D.I. et al. Combined contrast-enhanced power Doppler and real-time sonoelastography performed during EUS, used in the differential diagnosis of focal pancreatic masses (with videos). Gastrointest. Endosc. 2010; 72 (4): 739-747.

Contrast Enhanced Ultrasound for the Differentiation of Pancreatic Lesions. Literature Review

The role of ultrasound is well-known to be the noninvasive imaging modality chosen for the first evaluation of the pancreas. The advent of ultrasound contrast agents has raised the possibility of techniques to identify and differential diagnosis of pancreatic lesions. Analysis of the literature over the past 20 years has shown the advantages and disadvantages of various ultrasound in the evaluation of focal lesions of the pancreas.

Keywords:
ультразвуковая диагностика, контраст, поджелудочная железа, ultrasound, contrast, pancreas